Literature DB >> 31394013

Estimating the decision curve and its precision from three study designs.

Ruth M Pfeiffer1, Mitchell H Gail1.   

Abstract

The decision curve plots the net benefit (NB) of a risk model for making decisions over a range of risk thresholds, corresponding to different ratios of misclassification costs. We discuss three methods to estimate the decision curve, together with corresponding methods of inference and methods to compare two risk models at a given risk threshold. One method uses risks (R) and a binary event indicator (Y) on the entire validation cohort. This method makes no assumptions on how well-calibrated the risk model is nor on the incidence of disease in the population and is comparatively robust to model miscalibration. If one assumes that the model is well-calibrated, one can compute a much more precise estimate of NB based on risks R alone. However, if the risk model is miscalibrated, serious bias can result. Case-control data can also be used to estimate NB if the incidence (or prevalence) of the event ( Y=1 ) is known. This strategy has comparable efficiency to using the full (R,Y) data, and its efficiency is only modestly less than that for the full (R,Y) data if the incidence is estimated from the mean of Y. We estimate variances using influence functions and propose a bootstrap procedure to obtain simultaneous confidence bands around the decision curve for a range of thresholds. The influence function approach to estimate variances can also be applied to cohorts derived from complex survey samples instead of simple random samples.
© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  bias; case-control study; cost function; cross-sectional data; model assessment; net benefit; risk model

Mesh:

Year:  2019        PMID: 31394013      PMCID: PMC8620346          DOI: 10.1002/bimj.201800240

Source DB:  PubMed          Journal:  Biom J        ISSN: 0323-3847            Impact factor:   1.715


  17 in total

1.  Calibration of risk prediction models: impact on decision-analytic performance.

Authors:  Ben Van Calster; Andrew J Vickers
Journal:  Med Decis Making       Date:  2014-08-25       Impact factor: 2.583

2.  On criteria for evaluating models of absolute risk.

Authors:  Mitchell H Gail; Ruth M Pfeiffer
Journal:  Biostatistics       Date:  2005-04       Impact factor: 5.899

3.  Validation studies for models projecting the risk of invasive and total breast cancer incidence.

Authors:  J P Costantino; M H Gail; D Pee; S Anderson; C K Redmond; J Benichou; H S Wieand
Journal:  J Natl Cancer Inst       Date:  1999-09-15       Impact factor: 13.506

4.  Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older.

Authors:  Andrew N Freedman; Binbing Yu; Mitchell H Gail; Joseph P Costantino; Barry I Graubard; Victor G Vogel; Garnet L Anderson; Worta McCaskill-Stevens
Journal:  J Clin Oncol       Date:  2011-05-02       Impact factor: 44.544

5.  Overall Survival Prediction and Usefulness of Second-Line Chemotherapy in Advanced Pancreatic Adenocarcinoma.

Authors:  Angélique Vienot; Guillaume Beinse; Christophe Louvet; Louis de Mestier; Aurélia Meurisse; Francine Fein; Bruno Heyd; Denis Cleau; Christelle d'Engremont; Anne-Claire Dupont-Gossart; Zaher Lakkis; Christophe Tournigand; Olivier Bouché; Benoît Rousseau; Cindy Neuzillet; Franck Bonnetain; Christophe Borg; Dewi Vernerey
Journal:  J Natl Cancer Inst       Date:  2017-10-01       Impact factor: 13.506

6.  Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.

Authors:  M H Gail; L A Brinton; D P Byar; D K Corle; S B Green; C Schairer; J J Mulvihill
Journal:  J Natl Cancer Inst       Date:  1989-12-20       Impact factor: 13.506

7.  20-year outcomes following conservative management of clinically localized prostate cancer.

Authors:  Peter C Albertsen; James A Hanley; Judith Fine
Journal:  JAMA       Date:  2005-05-04       Impact factor: 56.272

8.  Decision curve analysis: a novel method for evaluating prediction models.

Authors:  Andrew J Vickers; Elena B Elkin
Journal:  Med Decis Making       Date:  2006 Nov-Dec       Impact factor: 2.583

9.  Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers.

Authors:  Andrew J Vickers; Angel M Cronin; Elena B Elkin; Mithat Gonen
Journal:  BMC Med Inform Decis Mak       Date:  2008-11-26       Impact factor: 2.796

10.  Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies.

Authors:  Ruth M Pfeiffer; Yikyung Park; Aimée R Kreimer; James V Lacey; David Pee; Robert T Greenlee; Saundra S Buys; Albert Hollenbeck; Bernard Rosner; Mitchell H Gail; Patricia Hartge
Journal:  PLoS Med       Date:  2013-07-30       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.